Announcement on Voluntary Disclosure of Receiving the Notice of Approval for Clinical Trials of HP515 Tablets for the Treatment of Non-alcoholic Steatohepatitis (NASH)
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment